Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
Epigenomics
|
June 24, 2016
MethylMeter(®): bisulfite-free quantitative and sensitive DNA methylation profiling and mutation detection in FFPE samples
David McCarthy, Walter Pulverer, Andreas Weinhaeusel, et al.
Plos One
|
July 4, 2014
Anti-miRs competitively inhibit microRNAs in Argonaute complexes
Daniel J Hogan, Thomas M Vincent, Sarah Fish, et al.
Human Gene Therapy Methods
|
October 16, 2015
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-Fluorouracil-Mediated Cytotoxicity in Multiple Human Cancer Types
Chris G Twitty, Oscar R Diago, Daniel J Hogan, et al.
Plos Biology
|
November 11, 2009
Concordant regulation of translation and mRNA abundance for hundreds of targets of a human microRNA
David G Hendrickson, Daniel J Hogan, Heather L McCullough, et al.
Journal of Molecular Evolution
|
March 4, 2003
Macronuclear molecules encoding actins in spirotrichs
Katie E Croft, Andrew B Dalby, Daniel J Hogan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 28, 2018
Molecular Analyses Support the Safety and Activity of Retroviral Replicating Vector Toca 511 in Patients
Daniel J Hogan, Jay-Jiguang Zhu, Oscar R Diago, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 21, 2020
Molecular and Immunologic Signatures are Related to Clinical Benefit from Treatment with Vocimagene Amiretrorepvec (Toca 511) and 5-Fluorocytosine (Toca FC) in Patients with Glioma
William P Accomando, Aliz R Rao, Daniel J Hogan, et al.
Journal of Drugs in Dermatology : JDD
|
April 3, 2008
Hydrocortisone butyrate 0.1% lotion in the treatment of atopic dermatitis in pediatric subjects
Robert Matheson, Steven Kempers, Debra Breneman, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
August 22, 2025
A phase 1B trial of vocimagene amiretrorepvec in patients with advanced solid tumors: Safety, tumor homing, and immune modulatory effects
Jaime R Merchan, Jordi Rodon, Shree Venkat, et al.
Elife
|
November 19, 2014
miR-142 regulates the tumorigenicity of human breast cancer stem cells through the canonical WNT signaling pathway
Taichi Isobe, Shigeo Hisamori, Daniel J Hogan, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
Epigenomics
|
June 24, 2016
MethylMeter(®): bisulfite-free quantitative and sensitive DNA methylation profiling and mutation detection in FFPE samples
David McCarthy, Walter Pulverer, Andreas Weinhaeusel, et al.
Plos One
|
July 4, 2014
Anti-miRs competitively inhibit microRNAs in Argonaute complexes
Daniel J Hogan, Thomas M Vincent, Sarah Fish, et al.
Human Gene Therapy Methods
|
October 16, 2015
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-Fluorouracil-Mediated Cytotoxicity in Multiple Human Cancer Types
Chris G Twitty, Oscar R Diago, Daniel J Hogan, et al.
Plos Biology
|
November 11, 2009
Concordant regulation of translation and mRNA abundance for hundreds of targets of a human microRNA
David G Hendrickson, Daniel J Hogan, Heather L McCullough, et al.
Journal of Molecular Evolution
|
March 4, 2003
Macronuclear molecules encoding actins in spirotrichs
Katie E Croft, Andrew B Dalby, Daniel J Hogan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 28, 2018
Molecular Analyses Support the Safety and Activity of Retroviral Replicating Vector Toca 511 in Patients
Daniel J Hogan, Jay-Jiguang Zhu, Oscar R Diago, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 21, 2020
Molecular and Immunologic Signatures are Related to Clinical Benefit from Treatment with Vocimagene Amiretrorepvec (Toca 511) and 5-Fluorocytosine (Toca FC) in Patients with Glioma
William P Accomando, Aliz R Rao, Daniel J Hogan, et al.
Journal of Drugs in Dermatology : JDD
|
April 3, 2008
Hydrocortisone butyrate 0.1% lotion in the treatment of atopic dermatitis in pediatric subjects
Robert Matheson, Steven Kempers, Debra Breneman, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
August 22, 2025
A phase 1B trial of vocimagene amiretrorepvec in patients with advanced solid tumors: Safety, tumor homing, and immune modulatory effects
Jaime R Merchan, Jordi Rodon, Shree Venkat, et al.
Elife
|
November 19, 2014
miR-142 regulates the tumorigenicity of human breast cancer stem cells through the canonical WNT signaling pathway
Taichi Isobe, Shigeo Hisamori, Daniel J Hogan, et al.
Page
of 5